Laman UtamaSNPHF • OTCMKTS
add
Santen Pharmaceutical Co Ltd
Tutup sebelumnya
$9.80
Julat tahun
$9.80 - $12.46
Permodalan pasaran
495.30B JPY
Bilangan Purata
7.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
TYO
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (JPY) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 76.37B | -0.85% |
Perbelanjaan pengendalian | 30.91B | -8.61% |
Pendapatan bersih | 8.69B | 18.56% |
Margin untung bersih | 11.38 | 19.54% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 15.83B | 0.55% |
Kadar cukai berkesan | 24.64% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (JPY) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 77.85B | -5.09% |
Jumlah aset | 398.31B | -6.90% |
Jumlah liabiliti | 115.10B | -11.35% |
Jumlah ekuiti | 283.21B | — |
Syer tertunggak | 341.35J | — |
Harga kepada buku | 0.01 | — |
Pulangan pada aset | 7.01% | — |
Pulangan pada modal | 9.91% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (JPY) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 8.69B | 18.56% |
Tunai daripada operasi | 13.73B | -56.70% |
Tunai daripada pelaburan | -2.77B | -42.37% |
Tunai daripada pembiayaan | -20.22B | -73.43% |
Perubahan bersih dalam tunai | -6.59B | -138.09% |
Aliran tunai bebas | 9.01B | -68.47% |
Perihal
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
Diasaskan
1890
Ibu pejabat
Tapak web
Pekerja
3,744
